Next Article in Journal
100 Years of Sanatorium in Rudka—Report of Celebration of Anniversary
Previous Article in Journal
D-dimer in Diagnosis and Treatment of Pulmonary Embolism
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
ARM
Volume 77
Issue 3
10.5603/ARM.27809
arm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Advances in Respiratory Medicine is published by MDPI from Volume 90 Issue 4 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Via Medica.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Multidrug Resistance Tuberculosis—Current Problems

by
Katarzyna Kruczak
* and
Ewa Niżankowska-Mogilnicka
Klinika Pulmonologii, II Katedra Chorób Wewnętrznych, Collegium Medicum Uniwersytetu Jagiellońskiego w Krakowie, ul. Skawińska 8, 31-066 Kraków, Poland
*
Author to whom correspondence should be addressed.
Adv. Respir. Med. 2009, 77(3), 276-283; https://doi.org/10.5603/ARM.27809
Submission received: 14 May 2008 / Revised: 23 April 2009 / Accepted: 23 April 2009 / Published: 23 April 2009

Abstract

The rising occurrence of multidrug-resistant tuberculosis (MDR-TB), defined as resistance to at least isoniazid and rifampicin, is a serious worldwide problem. The treatment of MDR-TB with alternative chemotherapy is difficult due to side-effects and treatment duration. It is also very expensive and sometimes unsuccessful. DOTS and DOTS-Plus strategy are necessary to achieve a good tuberculosis control.
Keywords: multidrug resistant tuberculosis; extensively drug resistant tuberculosis; DOTS-Plus multidrug resistant tuberculosis; extensively drug resistant tuberculosis; DOTS-Plus

Share and Cite

MDPI and ACS Style

Kruczak, K.; Niżankowska-Mogilnicka, E. Multidrug Resistance Tuberculosis—Current Problems. Adv. Respir. Med. 2009, 77, 276-283. https://doi.org/10.5603/ARM.27809

AMA Style

Kruczak K, Niżankowska-Mogilnicka E. Multidrug Resistance Tuberculosis—Current Problems. Advances in Respiratory Medicine. 2009; 77(3):276-283. https://doi.org/10.5603/ARM.27809

Chicago/Turabian Style

Kruczak, Katarzyna, and Ewa Niżankowska-Mogilnicka. 2009. "Multidrug Resistance Tuberculosis—Current Problems" Advances in Respiratory Medicine 77, no. 3: 276-283. https://doi.org/10.5603/ARM.27809

APA Style

Kruczak, K., & Niżankowska-Mogilnicka, E. (2009). Multidrug Resistance Tuberculosis—Current Problems. Advances in Respiratory Medicine, 77(3), 276-283. https://doi.org/10.5603/ARM.27809

Article Metrics

Back to TopTop